Coronary stenting in a patient with single coronary artery and double-vessel disease!

Soumen Devidutta1, Gautam Sharma, Priya Jagia

  • 1Department of Cardiology, All India Institute of Medical Sciences, New Delhi 110029, India.

Insights

This study details the successful stenting of a rare single coronary artery anomaly in a patient experiencing exertional angina. Percutaneous intervention relieved symptoms, highlighting treatment options for this uncommon condition.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Single coronary artery (SCA) is a rare congenital anomaly with a prevalence of 0.024%-0.066%.
  • SCAs are typically asymptomatic, making symptomatic cases noteworthy.
  • Atherosclerotic disease in anomalous coronary arteries presents unique challenges.

Observation:

  • A 52-year-old female presented with exertional angina (Class II).
  • Coronary angiography revealed an anomalous single coronary artery originating from the left coronary sinus.
  • The anomalous artery had significant stenoses in its left anterior descending and circumflex branches.

Findings:

  • Percutaneous coronary intervention (PCI) was successfully performed on the stenosed segments of the anomalous single coronary artery.
  • Following PCI, the patient's exertional angina symptoms resolved.
  • This case demonstrates the feasibility of treating atherosclerotic disease within a single coronary artery system.

Implications:

  • Intervention on rare coronary anomalies like SCA requires careful consideration of anatomical variations.
  • Successful PCI in this case suggests that standard interventional techniques can be adapted for SCA.
  • Further research into optimal management strategies for atherosclerotic disease in SCA patients is warranted.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...